NeuN expression and neuronal apoptosis in Sham and severely injured groups. حسب Xinhui Zhang (1624039)

الموضوعات:

Constructing the T10 spinal cord injury model. حسب Xinhui Zhang (1624039)

الموضوعات:

Expression of NeuN and CIRBP proteins in Sham and severely injured groups. حسب Xinhui Zhang (1624039)

الموضوعات:

Expression of IBA1 and CIRBP proteins in Sham and severely injured groups. حسب Xinhui Zhang (1624039)

الموضوعات:

Statistically Significant Results for Heart Rate Variability (HRV) Indices with Judgment Variables as Covariates. حسب David Vagni (8060432)

الموضوعات:

Pan-cancer analyses of ANGPTL4 expression and its prognostic significance in the TCGA database. حسب Yu Zhang (12946)

الموضوعات:

Pan-cancer analyses of NFKB2 expression and its prognostic significance in the TCGA database. حسب Yu Zhang (12946)

الموضوعات:

<i>upd3</i> loss-of-function mutations suppress the synthetic lethal phenotype of <i>Gpdh1</i>^{<i>A10/B18</i>}<i>; Ldh</i>^<i>16/17</i> double mutants. حسب Madhulika Rai (4352803)

Significant clusters: Coronal PET images showing brain regions with significant (p < 0.001 and K > 50) metabolic inhibition (A-G) and activation (H-I) in rats following cocaine sel... حسب Christopher Rowan (21499924)

S1 File - Utilization of psychotropic drugs in Serbia from 2006 to 2021: Patterns before and during the COVID-19 pandemic حسب Jelena Filimonovic (22305307)

الموضوعات:

Anion-Assisted Glycosylation of Galactose: A Computational Study حسب Kerli Tali (22769704)

الموضوعات:

RNAi targeting of <i>upd3</i> expression in muscle of <i>Gpdh1; Ldh</i> double mutant partially suppresses the developmental arrest phenotype. حسب Madhulika Rai (4352803)

Fig 3 - حسب Razieh Bidhendi-Yarandi (7139387)

الموضوعات:

<i>Gpdh1; Ldh</i> double mutants display increased <i>upd3</i> expression. حسب Madhulika Rai (4352803)

Glucose/galactose with extended interferon-priming does not impact levels of ISG RNAs or non-ISG proteins levels. حسب Tyron Chang (9922533)

Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"